Aurobindo gets FDA approval for pair of new generics
EAST WINDSOR, N.J. — Aurobindo Pharma Ltd. has received Food and Drug Administration approval for two new generic drug products: amlodipine and olmesartan medoxomil tablets, and glipizide extended-release tablets. Aurobindo said Monday that its amlodipine and olmesartan medoxomil product comes in dosages of 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40
